Fresenius Kabi Recalls Ketorolac Tromethamine Injection

Fresenius Kabi USA has recalled a single lot of pain and inflammation medication Ketorolac Tromethamine in the form of injection for the potential presence of particulate matter, the U.S. Food and Drug Administration or FDA said in a statement. The particulate matter was found in reserve sample vials.